<html>
<body>

	<div align="justify" style="padding-right: 8px">

		<p>
			<bold>A global biopharma focused on severe diseases</bold>
			with operations in approximately 40 countries and global revenue of €
			3.4 billion in 2013.
		</p>
		<p>
			<bold>• We combine biology and chemistry to make major
			breakthroughs.</bold>
			By integrating our expertise in large, antibody-based molecules and
			small, chemically-derived molecules, we can offer families with
			severe diseases and their specialist physicians the advantages of
			both large and small molecules to produce extraordinary
			breakthroughs.
		</p>
		<p>
			<bold>•We partner with the leaders in the pharmaceutical
			industry.</bold>
			The complexities of severe diseases are beyond the expertise and
			resources of a single organisation. That is why we have teamed up
			with partners - we play to our strengths and tap into the
			organisations with greater or complementary strengths
		</p>

	</div>

</body>
</html>
